demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 prophylaxis (excluding children)
Sinopharm Beijing (BBIBP-CorV) Ashmawy Rearte Xia ... Sultan Kanokudom

2 studies excluded by filtering options 2

9226 Tawinprai, 2022 2100excludednot a RCTrisk of bias not avaialble
9490 Greish, 2022 2100excludednot a RCTrisk of bias not avaialble